US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.29

+0.59351.71%

Post-market: 35.380.0865+0.25%16:00 EDT

Volume:148

Turnover:5K

Market Cap:16.59M

PE:- -

High:35.29

Open:35.23

Low:35.23

Close:34.70

52wk High:37.90

52wk Low:30.79

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.41

T/O Rate:0.03%

Dividend:0.41

Dividend Rate:1.16%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Verastem announces data from analysis of Phase 2 RAMP 201 trial

Novartis to License Drug from China's Abogen in up to $7.8 Billion Deal

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS

Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion

MT Newswires Live

Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%

Alkermes (ALKS), What Is Behind The Fresh Attention?

Simply Wall St.

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Sector Update: Healthcare

MT Newswires Live

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MEDX/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2935,"timestamp":1791576000000,"preClose":34.7,"halted":0,"volume":148,"hourTrading":{"tag":"盘后","latestPrice":35.38,"preClose":35.2935,"latestTime":"16:00 EDT","volume":1,"amount":35.38,"timestamp":1791576001394,"change":0.0865,"changeRate":0.002451,"amplitude":0},"delay":0,"changeRate":0.017103746397694488,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Market Closed","change":0.5935,"latestTime":"10-09 16:00:00 EDT","open":35.23,"high":35.2935,"low":35.23,"amount":5235,"amplitude":0.00183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.7,"sharesOutstanding":569946,"nav":34.78,"aum":16344721.88,"dividendRate":0.011611,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.38,"preClose":35.2935,"latestTime":"16:00 EDT","volume":1,"amount":35.38,"timestamp":1791576001394,"change":0.0865,"changeRate":0.002451,"amplitude":0},"volumeRatio":0.4095183917061679},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4095183917061679,"shares":469946,"dividePrice":0.4098,"high":35.2935,"amplitude":0.00183,"preClose":34.7,"low":35.23,"week52Low":30.79,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2935,"eps":0,"divideRate":0.011611,"volume":148,"delay":0,"ttmEps":0,"open":35.23,"prevYearClose":33.2024,"prevWeekClose":34.6588,"prevMonthClose":35.2817,"prevQuarterClose":35.2817,"fiveDayClose":34.6588,"twentyDayClose":34.9572,"sixtyDayClose":35.3775},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","03160","IDNA","MEDX","BK4555","TM","BK4588","CELC","BBP","SYNB","NVIB","HYLG","IBB","IEIH","BK4585","BK4099","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672005719","title":"Verastem announces data from analysis of Phase 2 RAMP 201 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672005719","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672005719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940914,"startTime":"0","endTime":"0","summary":"Verastem (VSTM) Oncology announced data from a new molecular profiling and tumor biomarker analysis of the Phase 2 RAMP 201 clinical trial of avuto...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verastem-announces-data-from-analysis-of-phase-2-ramp-201-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verastem-announces-data-from-analysis-of-phase-2-ramp-201-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VSTM","IDNA","MEDX","HYLG","BK4139","NVIB","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716928","title":"Novartis to License Drug from China's Abogen in up to $7.8 Billion Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716928","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716928?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:35","pubTimestamp":1790937300,"startTime":"0","endTime":"0","summary":"Novartis struck a deal valued at up to $7.8 billion to license a drug candidate from China's Abogen Biosciences and gain options over future therapies, the latest tie-up between a big Western drugmaker and a Chinese upstart.The Swiss drugmaker is paying $575 million upfront and could make additional payments of up to $7.2 billion if options on all programs are exercised, Abogen said Friday.Under the deal, Novartis will acquire worldwide rights over Abogen's lead drug candidate, called ABO2203, and get an exclusive option to license other next-generation therapeutic assets developed on Abogen's RNA platform, the Chinese company said.Abogen said its lead drug has potential to transform the treatment landscape for patients with autoimmune diseases. The drug uses messenger RNA to boost the body's production of a type of antibodies.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0002141913.USD","BK4578","BK4007","MEDX","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","BK4585","IE00B4R5TH58.HKD","LU0211331839.USD","IE00B2B36J28.USD","LU0320765489.SGD","LU0208291251.USD","PPH","IE00BFTCPJ56.SGD","NVS","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716311","title":"Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716311","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716311?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:05","pubTimestamp":1790935529,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000M9KFDE8.USD","BK4534","LU2471134952.CNY","SG9999013999.USD","LU1496350502.SGD","SGXZ57979304.SGD","BK4592","LU2896262040.SGD","LU1732800096.USD","IE0002270589.USD","JDOC","IXJ","MEDX","JNJ","LU1043141396.HKD","RXL","IE00BDGV0183.EUR","BMED","LU0162691827.USD","LU0426412945.USD","IE00BJT1NW94.SGD","LU0738911758.USD","LU2505996509.AUD","IYH","LU1066053197.SGD","SG9999002224.SGD","LU2417539215.USD","TRUH","BK4588","IE00B19Z3B42.SGD","LU2468319806.SGD","XLV","IE000WAW04H5.SGD","LU0466842654.USD","LU2430703251.USD","LU1551013425.SGD","PJP","LU0640476718.USD","IE00B2B36J28.USD","IHE","FTXH","FHLC","VHT","LU0234570918.USD","LU0203345920.USD","BK4581","LU0994945656.USD","LU1551013342.USD","LU2236285917.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715109","title":"Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715109?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:01","pubTimestamp":1790935267,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says ICOTYDE sustains psoriasis skin clearance through 2 years in Phase 3 ICONIC-TOTAL studyJohnson & Johnson disclosed new two-year Phase 3 ICONIC-TOTAL results for ICOTYDE (icotrok","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8bWfkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BBT3K403.USD","MEDX","LU2129689605.HKD","FTXH","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","TRUH","IHE","VHT","LU1043141123.HKD","BK4592","LU1061106388.HKD","LU1430594728.SGD","GDOC","LU0162691827.USD","FHLC","LU1732800096.USD","LU1043141396.HKD","LU1629891620.HKD","JNJ","IE00B4R5TH58.HKD","BMED","LU2430703251.USD","SG9999001176.USD","LU2417539215.USD","XLV","IXJ","JDOC","LU0820561818.USD","IYH","LU0234572021.USD","PJP","LU0994945656.USD","LU1066051225.USD","LU2456880835.USD","LU2347655156.SGD","SG9999002224.SGD","LU1066051811.HKD","LU0545039389.USD","LU1674673691.USD","SG9999001440.SGD","LU0426412945.USD","LU2896262040.SGD","IE00BLSP4452.SGD","LU0072461881.USD","LU0738911758.USD","IE0000B7K699.USD","RXL","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971590","title":"J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971590?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0162691827.USD","LU1674673691.USD","LU0320765646.SGD","LU1221951046.USD","JDOC","LU1061106388.HKD","LU2347655156.SGD","LU2471134879.HKD","LU1551013342.USD","IXJ","LU0820561909.HKD","LU1989771016.USD","IHE","LU1066051498.USD","BK4581","LU0426417589.USD","LU2129689605.HKD","LU2592432038.USD","LU0820562030.AUD","LU1551013425.SGD","VHT","LU1935042991.SGD","XLV","FHLC","LU0234572021.USD","BK4568","LU1162221912.USD","SGXZ80539844.SGD","LU0912757837.SGD","LU0057025933.USD","MEDX","IE00B19Z3581.USD","PJP","BMED","FTXH","IE00BFTCPJ56.SGD","LU0072461881.USD","IYH","IE00B4R5TH58.HKD","LU0795875169.SGD","LU0882574055.USD","GDOC","TRUH","IE00BLSP4452.SGD","LU1121112475.USD","RXL","LU0426412945.USD","JNJ","IE0001KFT4U8.USD","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672900715","title":"Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672900715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672900715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JNJ","LU0203347892.USD","LU0432979614.USD","LU0820562030.AUD","IYH","XLV","LU0122379950.USD","LU1674673691.USD","IE00BVYPNV92.GBP","LU0472753341.HKD","LU1551013342.USD","LU1267930813.SGD","IHE","LU0511384066.AUD","IE00BKVL7J92.USD","RXL","TRUH","IE00BDGV0183.EUR","FTXH","IXJ","LU0820561909.HKD","IE00BGHQF631.EUR","LU2750360641.GBP","IE00BVYPNW00.USD","LU0795875086.SGD","IE00BSNM7G36.USD","BK4581","LU0882574055.USD","PJP","IE0009355771.USD","BMED","MEDX","LU0234570918.USD","LU1066051225.USD","LU1989771016.USD","BK4550","LU0203345920.USD","LU1228905037.USD","VHT","LU0889566641.SGD","LU1430594728.SGD","JDOC","LU1066053197.SGD","LU1003077747.HKD","GDOC","LU0792757196.USD","BK4568","LU0070217475.USD","LU1221951129.SGD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715972","title":"J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715972?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0072461881.USD","JDOC","LU1732800096.USD","LU2129689514.USD","LU1074936037.SGD","IE000BZT7R73.USD","LU0345770993.USD","XLV","LU2456880835.USD","LU0964807845.USD","IE000F7OJYX1.SGD","BK4588","IE000MB6IJN5.SGD","LU1043141123.HKD","IE00B1BXHZ80.USD","MEDX","LU1145028129.USD","SG9999002232.USD","LU2505996681.GBP","RXL","VHT","IXJ","LU1983299246.USD","PJP","IE00BFTCPJ56.SGD","LU1221951129.SGD","LU1267930813.SGD","GDOC","LU0210528500.USD","LU1506573853.SGD","BMED","LU0162691827.USD","FHLC","TRUH","IYH","LU0203347892.USD","IE00B19Z3B42.SGD","LU0820562030.AUD","BK4581","LU2471134879.HKD","FTXH","LU1551013425.SGD","LU0545562505.USD","IHE","JNJ","LU1914381329.SGD","LU0345769128.USD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171597","title":"J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171597?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","MEDX","LU0792757196.USD","IE00BVYPNV92.GBP","BMED","LU1674673691.USD","LU2750360641.GBP","IHE","IE00BGHQF631.EUR","LU0122379950.USD","LU0472753341.HKD","LU0820561909.HKD","GDOC","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU0203347892.USD","LU0432979614.USD","LU0820562030.AUD","LU1228905037.USD","LU0882574055.USD","LU1551013342.USD","LU0203345920.USD","IYH","IE00BVYPNW00.USD","FTXH","LU1430594728.SGD","FHLC","BK4568","LU1989771016.USD","BK4550","PJP","JDOC","IE0009355771.USD","JNJ","XLV","LU0795875086.SGD","LU1221951129.SGD","TRUH","LU1003077747.HKD","RXL","LU0234570918.USD","VHT","LU0511384066.AUD","IXJ","IE00BKVL7J92.USD","LU0889566641.SGD","LU0070217475.USD","BK4581","LU1267930813.SGD","LU1066051225.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672107715","title":"Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672107715","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672107715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:55","pubTimestamp":1790934913,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced a clinical trial collaboration agreement with Daiichi Sankyo (DSNKY) and AstraZeneca (AZN) to evaluate ivonesc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443895.HKD","LU2488822045.USD","IDNA","LU0889565916.HKD","LU0708994859.HKD","BK4588","LU2462157665.USD","BK4568","LU2237443549.SGD","LU2237443978.SGD","SMMT","LU0310800379.SGD","MEDX","LU2237443382.USD","LU2237443465.HKD","AZNH","LU1829250122.USD","GDOC","BK4139","LU0029864427.USD","LU2237443622.USD","LU0128525929.USD","LU2236285917.USD","DSNKY","LU1267930573.SGD","BK4007","LU2089984988.USD","LENZ","LU0058720904.USD","LU2456880835.USD","AZN","LU0320765992.SGD","BK4539","LU2468319806.SGD","IE00B3T34201.USD","LU0289739699.SGD","BK4585","LU0109394709.USD","NVIB","HYLG","LU2417539215.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU1481599808.USD","LU0122379950.USD","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","02096","BK0196","LU0354030511.USD","03933","LU0053666078.USD","LU2213496289.HKD","LU2357627491.SGD","LU0149534421.HKD","LU0203201768.USD","LU0234572021.USD","BK4559","LU1267930227.SGD","BK4585","LU1989772923.USD","LU1655091616.SGD","SG9999018865.SGD","LU2324357040.USD","LU2114397693.USD","LU1116320901.HKD","SG9999003800.SGD","LU0708995401.HKD","LU1923622614.USD","IE00B1XK9C88.USD","LU0109981661.USD","LU1868836757.USD","LU1146622755.USD","PPH","SG9999004220.SGD","LU0496365809.HKD","LU0965509010.AUD","LU1261432733.SGD","LU2491050071.SGD","LU1894683348.USD","LU1078025761.USD","LU0795875086.SGD","LU2399975544.HKD","LU0882574055.USD","LU1226287792.SGD","BK4566","LU2495084118.USD","LU0976567544.SGD","LU0889566641.SGD","LU1309081286.SGD","LU2580892862.HKD","LU1267930573.SGD","LU1781817850.SGD","LU1291159041.SGD","LU0315179316.USD","LU0575583348.USD","LU0109394709.USD","PFE","LU1064927863.SGD","IE00BBT3K403.USD","LU1670628061.USD","TRUH","LU0634319403.HKD","LU0882574139.USD","LU1019634622.SGD","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","LU1170363599.USD","LU1941712264.USD","LU0960981461.USD","KURE","IE00BKDWB100.SGD","LU1003076772.USD","LU2039709279.SGD","LU0477156953.USD","IE000WAW04H5.SGD","LU0348827113.USD","LU0130102774.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU2097828805.USD","IE00BFTCPJ56.SGD","LU0823434740.USD","LU2125909593.SGD","LU1969619763.USD","LU1127390331.HKD","LU1064130708.USD","LU2089984988.USD","LU0868494617.USD","LU2129689431.USD","09995","LU0963555726.SGD","LU1496350171.SGD","SG9999001440.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0502904849.HKD","GLAM","IE00B4JS1V06.HKD","LU2552382132.HKD","LU2347655156.SGD","LU0553294199.USD","LU0106261372.USD","LU1400636657.SGD","LU1712237335.SGD","LU2539964713.USD","LU0395794307.EUR","LU1548497426.USD","LU0823399737.USD","ILDR","LU0079474960.USD","LU2362540622.SGD","LU2491049909.HKD","LU0969580561.USD","LU2023251221.USD","LU2111349929.HKD","THNR","BK4532","IE00BN29S564.USD","LU1226287529.USD","IE0002270589.USD","LU0889565080.SGD","LU1064131342.USD","LU2063271972.USD","LU2646069778.SGD","BK1589","LU2293690082.USD","IE00B3T34201.USD","LU2108987350.USD","IE00BFXG1179.USD","IXJ","IE000SO60NU8.SGD","LU0203347892.USD","BK0012","SMMT","01276","LU0326950275.SGD","LU0971552830.HKD","LU2896262040.SGD","BK4548","LU1098665638.USD","LU2125154778.USD","LU1093756325.SGD","LU1228905037.USD","LU0128525929.USD","CURE","LU1037948541.HKD","LU0784383803.USD","LU0114720955.EUR","MRK","LU0672654240.SGD","LU0949170772.SGD","LU0868494708.USD","LU1236620834.HKD","LU2279689827.SGD","LU2289578879.USD","LU2168563687.JPY","01530","IE00BN8TJ469.HKD","LU1496350502.SGD","IE000M9KFDE8.USD","LU0130517989.USD","LU1328277881.USD","IE00BLSP4239.USD","LU0171276677.USD","IE00BJJMRZ35.SGD","LU1046248800.SGD","LU0256863811.USD","IE0008368742.USD","LU0708994859.HKD","LU2129689514.USD","LU0323591593.USD","LU2242646821.SGD","LU0689472784.USD","LU0965509101.SGD","BK4535","LU0077335932.USD","LU1019632923.USD","LU0561508036.HKD","LU2293690249.USD","BK1191","LU0098860793.USD","LU1580142542.USD","LU1997244956.HKD","IBBQ","LU2264538146.SGD","LU2242644610.SGD","LU0210536198.USD","LU0289739699.SGD","LU0109391861.USD","LU0949170426.SGD","SGXZ99366536.SGD","LU1831875114.USD","LU0057025933.USD","MEDX","LU0306807586.USD","LU1323610961.USD","LU1941712348.USD","LU0985320562.USD","LU1015430645.USD","LU0096364046.USD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU2125909247.SGD","LU0545562505.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","LU1255011170.USD","IE00B031HY20.USD","LU2476274308.USD","LU0417516571.SGD","LU0889565916.HKD","LU2462591350.SGD","LU2347655073.USD","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","LU0971552673.USD","MHIP","LU0072461881.USD","IE00B3PB1722.GBP","HRTS","LU1732800096.USD","LU0140636845.USD","BMED","LU2237443549.SGD","LU2328871848.SGD","XLV","LU2491050154.USD","LU2468319806.SGD","600276","LU0471298777.SGD","LU0211331839.USD","LU0390134368.USD","LU0348784397.USD","LU0463099449.HKD","LU0348766576.USD","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","LU1153584641.USD","LU0316494557.USD","LU0354030438.USD","LU1035773651.USD","LU1074936037.SGD","IE000F7OJYX1.SGD","NVO","03165","BNTX","LU2133065610.SGD","WDNA","LU0972486137.USD","LU0011850046.USD","LU2242652126.USD","LU0640476718.USD","GDOC","LU2237443382.USD","SG9999014914.USD","LU0640478417.SGD","LU1979441026.SGD","LLYX","LU1003077747.HKD","IBB","LU2361044949.HKD","LU0320765646.SGD","IE0034235071.USD","LU2168564222.USD","BK0060","LLYZ","LU2596442595.SGD","LU2129689605.HKD","LU0124676726.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","IE00BGHQF631.EUR","IE00BPRC5H50.USD","BK1161","LU0310800965.SGD","IE00BFSS7M15.SGD","LU2236285917.USD","BK0183","LU1226288170.HKD","LU1273509221.SGD","LU0289961442.SGD","IE0008369823.USD","LU0211328371.USD","LU0067412154.USD","LU0417517546.SGD","SG9999014575.USD","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU2471134796.USD","BK4588","IE0004445239.USD","GSK.UK","BK4550","IE000MB6IJN5.SGD","IE00B775H168.HKD","LU0244354667.USD","LU0980610538.SGD","LU0265550946.USD","LU2087625088.SGD","LU1720050803.USD","LU2360106947.USD","IE00BZ1G4Q59.USD","BK0239","LU1813983027.USD","LU0417516902.SGD","LU1623119135.USD","LU0266013472.USD","LU0047473722.SGD","LU0499090636.EUR","LU1894683264.USD","LU0029864427.USD","LU1201861249.SGD","IE0004445015.USD","IE00BZ08YS42.EUR","SG9999011175.SGD","LU0265550359.USD","BK4592","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1032466523.USD","LU1188198961.HKD","LU0820561909.HKD","LU0455707207.USD","LLII","LU1064131003.USD","LU1670711040.USD","LU2097828474.EUR","LU1226288253.USD","LU2028103732.USD","LU2580892789.USD","LU0310799852.SGD","LU1670710661.SGD","LU2211815571.USD","LU0289739343.SGD","LU0786609619.USD","SG9999017495.SGD","LU1880407132.USD","LU0964807845.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU1152091754.HKD","LU1196032939.SGD","LU0943347566.SGD","IE00BWDBJ516.SGD","LU0321505439.SGD","LU0920783379.SGD","IE0000B7K699.USD","LU0957799991.USD","LU0965508806.USD","LU1116320737.USD","LU1119994496.HKD","LU0912757837.SGD","IE00BJLML261.HKD","LU2087621335.USD","LU1718418525.SGD","LU1934455277.USD","SG9999014880.SGD","LU2433249047.HKD","LU2168564495.EUR","LU1302929846.USD","LU2746668974.SGD","TMED","LU0726765562.USD","LU1162221912.USD","LU1093756168.USD","LU0069063385.USD","LU0320765489.SGD","IYH","LU1035775433.USD","LU1267930813.SGD","LU1691799644.USD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","LU1280957306.USD","LU0070302665.USD","MEDI","LU0540923850.HKD","LU1355424745.HKD","LU0203345920.USD","LU1997245177.USD","BK4534","LU2237443622.USD","LU1863844665.USD","SGXZ57979304.SGD","LU0094547139.USD","LU0985481810.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU1084165304.USD","LU0405327148.USD","SG9999001176.SGD","LU0225284248.USD","LU1699723380.USD","LU1934455863.HKD","SGXZ51526630.SGD","TBXU","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0942090050.USD","LU1807302812.USD","ABBV","AZN.UK","01093","LU0417516738.SGD","LU0857590862.USD","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","LU2750360641.GBP","LU2361045086.USD","IE0005OL40V9.USD","LU1585245621.USD","LU1839511570.USD","LU0256863902.USD","LU0320765059.SGD","LU1066051225.USD","SG9999014542.SGD","LU0306806265.USD","LU2362541513.USD","IE00BKPKM429.USD","IE00B42XCP33.USD","LU2023250330.USD","LU2168564149.EUR","LU0237698245.USD","LU0456855351.SGD","LU0545039389.USD","LU0880133367.SGD","LU0738911758.USD","LU1328615791.USD","LU0162691827.USD","LU1829250122.USD","IE0002141913.USD","LLY","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2461242641.AUD","RHHBY","LU2756315318.SGD","LU0058720904.USD","LU0345777659.USD","LU1244550221.USD","ELIL","LU0859254822.USD","NVOC","LU0827474353.SGD","LU1046234339.USD","LU1023059063.AUD","BK1521","LU1989772840.SGD","LU0661504455.SGD","SGXZ81514606.USD","SG9999015341.SGD","BK1587","LU0683600562.USD","LU0170899867.USD","LU2091194634.USD","LU0823416689.USD","LU1670756490.USD","IE00B1BXHZ80.USD","LU0128525689.USD","LU1868837300.USD","SG9999014906.USD","LU0607220059.USD","LU0072913022.USD","LU0006306889.USD","NVOH","IE00BQJZX424.USD","LU0795875169.SGD","LU1035777561.USD","IE00B3M56506.USD","IE00BK4W5L77.USD","LU2271345857.HKD","LU2456880835.USD","LU3187612489.SGD","SG9999014567.USD","LU0225771236.USD","LU1804176565.USD","LU0198837287.USD","IE00B5MMRT66.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU1232071149.USD","LU1037948897.HKD","LU1670627923.USD","LU1267930730.SGD","LU1993786604.SGD","LU0174119429.USD","LU0648001328.SGD","LU2097828714.EUR","LU1720051108.HKD","LU2097828631.EUR","LU1153585028.USD","NVS","LU2476274720.SGD","BK4599","BBH","IHE","LU0689626769.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","LU0526926950.USD","SG9999013999.USD","LU2417539215.USD","LU0353189763.USD","LU1883839398.USD","BK1574","LU1226287875.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","00013","LU2148510915.USD","IE0034235188.USD","LU1571399168.USD","LU1961090484.USD","LU2023250843.SGD","BK1583","HK0000165453.HKD","LU0405327494.USD","LU0471298694.HKD","LU0432979614.USD","BMY","LU1868836591.USD","688331","JDOC","RXL","NVOX","LU1051770623.HKD","LU1061106388.HKD","LU1670710588.SGD","IE00BKPKM643.USD","IE00B4R5TH58.HKD","LU0997586515.USD","LU1244550577.SGD","LU0321505868.SGD","LU1974910355.USD","01801","IE00BVYPNW00.USD","LU0203202063.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","BK0188","BK4581","BK4516","LU2361044865.SGD","688506","BK0028","LU0345777147.USD","LU1951186391.HKD","LU2089283258.USD","LU0466842654.USD","PJP","LU1152091168.USD","LU2106854487.HKD","LU2471134523.USD","IE00BK4W5M84.HKD","09926","LU0171293334.USD","LU2488822045.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1066053197.SGD","LU1989771016.USD","SG9999015978.USD","LU2552382215.SGD","LU1880407215.USD","LU1481600234.SGD","LU0047473722.EUR","PAWZ","LU2746668461.USD","BK1515","IE00B2B36J28.USD","LU0987226296.USD","LU1057294990.SGD","LU0348783233.USD","LU0385154629.USD","LU1069347547.HKD","LU0348825331.USD","LU2756315664.SGD","LU1487256676.USD","BK4007","LU0501845795.SGD","LU0784385840.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE00BLSP4452.SGD","LU0097036916.USD","BK1588","FTXH","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","BK4578","LU0161305163.EUR","LU0211326839.USD","LU2112291526.USD","LU0920840948.USD","SG9999014559.SGD","CANC","HCM","LU0964806797.USD","LU0887340254.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU1104425308.USD","LU0052756011.USD","LU1794554557.SGD","LU2125154935.USD","LU1988902786.USD","IE00B19Z3581.USD","LU0345770993.USD","LU1645745479.HKD","LU1820825898.SGD","VHT","LU0267386448.USD","LU0208291251.USD","BK4139","LU1929549753.HKD","LU1670711123.USD","IE0009355771.USD","LU0158827948.USD","GB00BDT5M118.USD","LU0348767384.USD","LU2362541273.HKD","LU0158827781.USD","LU1960683339.HKD","OZEM","LU1430594728.SGD","LU0784385170.HKD","LU0348735423.USD","BK4533","LU0353189680.USD","LU1868837136.USD","LU2778985437.USD","LU0823434583.USD","FHLC","LU0997586432.USD","LU1301847155.USD","03692","ELIS","LU1863844749.USD","LU0757432116.USD","LU1917777945.USD","AGNG","BK1593","BK5011","LU2089284900.SGD","LU1236620750.USD","LU1145028129.USD","LU2355687059.USD","LU1267930490.SGD","SG9999002224.SGD","LU0792757196.USD","LU2602419157.SGD","LU1228905540.USD","LU1069344957.HKD","BK4551","BK4568","LU0238689110.USD","LU1008478684.HKD","REGN","LU0154236417.USD","LU0211326755.USD","LU1997245094.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","LU2106854487.HKD","IBB","IYH","LU2133065610.SGD","BBH","LU1057294990.SGD","MEDX","SNY","LU0069063385.USD","XLV","LU0158827948.USD","LU1917777945.USD","TRUH","JDOC","IE00BJT1NW94.SGD","AGNG","LU0057025933.USD","LU0795875169.SGD","LU0053666078.USD","LU0203347892.USD","LU0965509283.SGD","TBXU","PJP","VHT","LU0417517546.SGD","LU0098860793.USD","IBBQ","REGN","LU1883839398.USD","FTXH","BK4599","LU2112291526.USD","LU0128525929.USD","FHLC","LU0029864427.USD","LU0211327993.USD","GLAM","LU0949170772.SGD","BK4585","LU1037948541.HKD","LU1244550577.SGD","PFE","PPH","ABBV","IXJ","LU1720051108.HKD","OZEM","RXL","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672608718","title":"Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672608718","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672608718?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:33","pubTimestamp":1790930014,"startTime":"0","endTime":"0","summary":"Novartis  entered into a licensing and option agreement with Abogen Biosciences to advance RNA-encoded therapeutics, Abogen said Friday.Under the agreement, Novartis receives an exclusive worldwide license to lead autoimmune asset ABO2203 along with options for future RNA platform programs, Abogen Biosciences said.Abogen Biosciences will receive $575 million upfront and remains eligible for up to $7.2 billion in milestone payments plus potential sales royalties, it said.The lead drug candidate uses mRNA to produce immune system cell engagers inside the body to clear B cells in patients with autoimmune diseases, the company added.Abogen said the agreement also gives Novartis options on other potential drug programs using its RNA technology, expanding the potential application of the platform beyond vaccines.The transaction remains subject to customary closing conditions, including required regulatory clearances.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4588","IE0002141913.USD","IE00B2B36J28.USD","LU0211331839.USD","MEDX","PPH","IE00B4R5TH58.HKD","BK4585","IE00BJT1NW94.SGD","BK4532","BK4578","BK4007","IE00BJJMRZ35.SGD","NVS","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166541763","title":"Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166541763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166541763?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:52","pubTimestamp":1790927535,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks broadly retreated, with InnoCare Pharma (09969) falling 8.38% to HK$13.55, RemeGen (09995) dropping 5.71% to HK$72.7, and 3SBio (01530) declining 4.95% to HK$15.75 as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK4588","688428","09969","LU2488822045.USD","MEDX","06978","BK1593","LU1969619763.USD","LU2148510915.USD","01530","BK1583","159992","BK4585","IBBQ","BK1161","LNGR","KCAI","LU1064131003.USD","BK1574","LU2328871848.SGD","09995","HK0000165453.HKD","BK0239","LU1064130708.USD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235796","title":"Alkermes (ALKS), What Is Behind The Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235796","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235796?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:21","pubTimestamp":1790904114,"startTime":"0","endTime":"0","summary":"Alkermes (NasdaqGS:ALKS) is back on investors’ radar after releasing phase 1 proof of concept data for ALKS 7290 in adults with ADHD, showing clinically meaningful symptom improvements and supportive safety findings.\nRecent trading tells a mixed story for Alkermes. The share price is around $40.54, with a 30 day share price return down 14.11% and a 90 day move lower by 25.72%. Yet the year to date share price return is up 43.45% and the 1 year total shareholder return sits at 29.69%,...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IBRN","MEDX","FBT","ALKS","PSCH","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672916767","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672916767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672916767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:28","pubTimestamp":1790890080,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 5.01% to $14.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Perrigo Co. PLC closed 38.10% below its 52-week high of $22.65, which the company reached on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Procter & Gamble Co.  fell 0.92% to $143.95, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 247,637 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UGE","LU1043141396.HKD","SG9999002232.USD","IHI","SG9999015341.SGD","LU1551013425.SGD","XLV","BMED","LU1221951129.SGD","RXL","JNJ","SGXZ80539844.SGD","MEDX","LU1162221912.USD","LU1506573853.SGD","PJP","LU0289961442.SGD","IE00B3PB1722.GBP","GDOC","FTXH","IE00B19Z3581.USD","LU0069063385.USD","LU1721429402.USD","IE000WAW04H5.SGD","FHLC","LU2112291526.USD","LU0289739343.SGD","XLP","PG","IE000F7OJYX1.SGD","SGXZ23171101.USD","JDOC","BK4534","TMED","FSTA","LU1718418525.SGD","VHT","LU2552382132.HKD","IE00BLSP4452.SGD","LU0994945656.USD","IHE","LU1721429741.USD","TRUO","TRUH","IXJ","LU0289739699.SGD","IYH","PRGO","LU0345769631.USD","ABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672764016","title":"Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764016","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764016?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:05","pubTimestamp":1790885100,"startTime":"0","endTime":"0","summary":"RADNOR, Pa., Oct.  01, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373386/0/en/mineralys-therapeutics-announces-presentation-of-lorundrostat-data-at-american-heart-association-hypertension-scientific-sessions-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LENZ","BK4117","AFG","BK4539","GDOC","MEDX","NVIB","HYLG","BK4139","BK4107","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","LU0385154629.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU2089284900.SGD","LU2491050154.USD","LU2461242641.AUD","AGNG","IE0004445015.USD","IE00B1BXHZ80.USD","LU0198837287.USD","LU2237438978.USD","LU2264538146.SGD","LU0079474960.USD","LU1988902786.USD","LU1548497426.USD","BK4516","IE0005OL40V9.USD","LU0823416689.USD","LU1093756168.USD","SGXZ31699556.SGD","LU1974910355.USD","LU0672654240.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU2237443895.HKD","LU2213496289.HKD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU1979441026.SGD","LU2168564149.EUR","SG9999013999.USD","SG9999001176.SGD","LU0096364046.USD","IE00B775H168.HKD","IE0004445239.USD","LU0256863902.USD","LU1127390331.HKD","LU1814569148.SGD","LU1720051108.HKD","LU1868836591.USD","IE00BWXC8680.SGD","LU0109394709.USD","LU2023251221.USD","LU2271345857.HKD","PJP","LU2491050071.SGD","SGXZ57979304.SGD","ELIS","LU1720051017.SGD","ELIL","LU0266013472.USD","LU0787776722.HKD","SG9999014898.SGD","LU2168564065.EUR","LABU","LU0106261372.USD","LU2106854487.HKD","FHLC","LU0345770993.USD","LU1868836914.USD","LU1267930730.SGD","CANC","IE0001KFT4U8.USD","GB00BDT5M118.USD","LU0471298777.SGD","LU1323610961.USD","IE00B4R5TH58.HKD","WDNA","LU1232071149.USD","LU0158827948.USD","TRUH","THNR","LU0320765992.SGD","MEDI","IE00BFTCPJ56.SGD","LU2357305700.SGD","LU2750360997.AUD","SGXZ51526630.SGD","LU2552382132.HKD","LLYZ","LU2168564495.EUR","LU2237443382.USD","LU2462591350.SGD","LU0432979614.USD","VHT","IE00BFSS7M15.SGD","IBB","IE00B1XK9C88.USD","IE00BJJMRX11.SGD","LU1069344957.HKD","LU1868837300.USD","SG9999017495.SGD","IHE","LU2236285917.USD","LU1057294990.SGD","LU0094547139.USD","LU0345770308.USD","LU0174119429.USD","LU0354030438.USD","SG9999001176.USD","LU2237443978.SGD","LU0122379950.USD","LU2063271972.USD","SG9999015986.USD","LU1804176565.USD","LU0689472784.USD","LU2087625088.SGD","BK4581","LU1366192091.USD","LU2168564222.USD","LU2237443465.HKD","BK4588","LLII","LU0823434740.USD","SG9999018857.SGD","SG9999014914.USD","LU0316494557.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","LU2471134952.CNY","IE00B2B36J28.USD","LU0889565916.HKD","LU2111349929.HKD","LU2468319806.SGD","LLYX","LU2602419157.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0203201768.USD","LU0820561909.HKD","LU0456855351.SGD","LU1551013425.SGD","LU2023250504.SGD","LU2265009873.SGD","LU0238689110.USD","LU0471298694.HKD","TMED","LU2750360641.GBP","LU2746668461.USD","LU1291159041.SGD","LU0820562030.AUD","LU2361044865.SGD","SGXZ99366536.SGD","LU1983299246.USD","LU0320765059.SGD","LU2237443549.SGD","LU0097036916.USD","LU1280957306.USD","LU0289739699.SGD","HRTS","LU0006306889.USD","IXJ","LU2089984988.USD","LLY","SG9999018865.SGD","ILDR","LU2237443622.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LU1035775433.USD","LU2361045086.USD","SG9999014906.USD","LU0708995401.HKD","LU0943347566.SGD","SG9999015978.USD","LU0417517546.SGD","LU0882574055.USD","LU0882574139.USD","LU1868836757.USD","XLV","LU0353189680.USD","LU2456880835.USD","LU1551013342.USD","LU2211815571.USD","GDOC","LU1623119135.USD","LU2028103732.USD","IE00BN29S564.USD","LU2112291526.USD","LU1629891620.HKD","LU0323591593.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU2552382215.SGD","LU1868837136.USD","LU0683600562.USD","LU2089283258.USD","LU0256863811.USD","LU2552382058.USD","OZEM","BK4585","RXL","LU0786609619.USD","LU0109391861.USD","LU0353189763.USD","LU2324357040.USD","LU2168563687.JPY","FTXH","LU2491049909.HKD","LU0203202063.USD","LU2360106947.USD","IYH","LU0210536198.USD","LU0133085943.USD","LU0225283273.USD","LU0964807845.USD","IE0002141913.USD","LU2471134796.USD","LU0466842654.USD","MEDX","IE00BFSS8Q28.SGD","LU0058720904.USD","LU2023250330.USD","LU0823434583.USD","LU1691799644.USD","LU0820561818.USD","LU2756315318.SGD","XBI","BK4533","LU2417539215.USD","LU1061106388.HKD","CURE","LU2896262040.SGD","BK4007","LU2108987350.USD","IE00BKDWB100.SGD","FHTX","LU2361044949.HKD","LU2471134523.USD","LU2471134879.HKD","PPH","SGXZ81514606.USD","BK4599","LU2746668974.SGD","SG9999015945.SGD","SG9999014880.SGD","LU0158827781.USD","LU1712237335.SGD","LU1064131342.USD","LU1917777945.USD","IE00BK4W5L77.USD","BK4139","SG9999015952.SGD","LU1989771016.USD","LU2756315664.SGD","LU0114720955.EUR","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PPH","IE00B4R5TH58.HKD","LU2125909247.SGD","LU1037948541.HKD","LU2468319806.SGD","VHT","LU2347655073.USD","GLAM","LU1720051017.SGD","LU1670628061.USD","FTXH","MEDX","LU0114720955.EUR","LU2125909593.SGD","LU0689626769.HKD","LU1670627923.USD","LU1430594728.SGD","LU0868494617.USD","LU1244550221.USD","BK4588","LU1989772840.SGD","DCF","BK4581","LU0472753341.HKD","LU1929549753.HKD","FHLC","LU1093756168.USD","ABBV","LU0726765562.USD","LU2433249047.HKD","LU2129689514.USD","PJP","IXJ","LU2089284900.SGD","XLV","BK4139","LU0795875169.SGD","SPHQ","TRUH","LU0256863902.USD","BK4533","JDOC","IYH","LABU","AGNG","SG9999011175.SGD","LU0965508806.USD","RXL","LU2089984988.USD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672769149","title":"Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2672769149","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672769149?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:54","pubTimestamp":1790877298,"startTime":"0","endTime":"0","summary":"Trump Medicare drug pricing model may apply to only four companies after exemptionsNEW YORK, Oct 1 (Reuters)-A Trump administration rule to cut hospital drug prices for Medicare patients may apply to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL1N45N0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LLII","LU1057294990.SGD","LU1548497426.USD","LU2471134796.USD","SG9999014880.SGD","LU0256863811.USD","SGXZ99366536.SGD","BK4533","LU0170899867.USD","BK4007","LU2211815571.USD","LU2023250504.SGD","PPH","LU1894683264.USD","LU1069344957.HKD","LU1988902786.USD","LU2236285917.USD","LU2468319806.SGD","SG9999018857.SGD","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999015945.SGD","LU1145028129.USD","LU1066053197.SGD","LU1366192091.USD","WDNA","LU2491049909.HKD","IE00B19Z3581.USD","LU1868837136.USD","SG9999015986.USD","TRUH","IE00BFSS7M15.SGD","LU2750360997.AUD","MEDX","LU1035775433.USD","LU1868836914.USD","RXL","CANC","OZEM","LU0417517546.SGD","SG9999011175.SGD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0432979614.USD","LU0471298777.SGD","LU0385154629.USD","LU0882574055.USD","LU1280957306.USD","LU2361044949.HKD","MEDI","LU0106261372.USD","LU0306806265.USD","BK4585","IE0009355771.USD","IE00BLSP4452.SGD","LU0820561909.HKD","THNR","LU1989771016.USD","MHIP","BK4550","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4592","FTXH","LU1061106388.HKD","SG9999013999.USD","LU1894683348.USD","LU2746668461.USD","LU1883839398.USD","SGXZ81514606.USD","LU0158827781.USD","LU2491050154.USD","LU0345770308.USD","LU0353189680.USD","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","LU0234572021.USD","LU0058720904.USD","LU0321505439.SGD","ILDR","LU0225771236.USD","LU0471298694.HKD","LU2750360641.GBP","SGXZ51526630.SGD","TMED","LU0466842654.USD","LU0820561818.USD","LU2237443549.SGD","BK4534","LU2596442595.SGD","LU0203201768.USD","SG9999002224.SGD","SG9999014898.SGD","LU2471134879.HKD","LU0823434583.USD","LU0672654240.SGD","LU2112291526.USD","IE0002270589.USD","LU2023251221.USD","LU2168564065.EUR","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU2168564495.EUR","IXJ","VHT","LU0823416689.USD","LU0354030511.USD","LU1093756168.USD","LU0787776722.HKD","GB00BDT5M118.USD","IE0004445239.USD","LU2089283258.USD","LU0079474960.USD","LU2462157665.USD","LU0109391861.USD","SG9999015978.USD","LLY","LU0198837287.USD","LU0354030438.USD","LU1064131342.USD","IE00B3T34201.USD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU0882574139.USD","LU1267930730.SGD","LU1868837300.USD","LLYZ","LU1623119135.USD","IE00BLSP4239.USD","PFE","IE00BK4W5L77.USD","SGXZ31699556.SGD","LU0320765992.SGD","BK4568","LU2265009873.SGD","GDOC","LU0708995401.HKD","LU0456855351.SGD","LU0889565916.HKD","SG9999014906.USD","AGNG","IE00B775H168.HKD","LU2271345857.HKD","LU0158827948.USD","LU2602419157.SGD","IE00BKDWB100.SGD","LU1232071149.USD","IE00BJJMRX11.SGD","CURE","LU0683600562.USD","LU1720051017.SGD","SG9999014914.USD","BK4599","LU2106854487.HKD","IE00B1XK9C88.USD","LU1974910355.USD","IYH","BK4588","LU0640476718.USD","LU2237443978.SGD","LU0985481810.HKD","LU2471134523.USD","LU2108987350.USD","LU1868836591.USD","SG9999002232.USD","IE00B4JS1V06.HKD","LU2417539215.USD","LU0786609619.USD","LU2462591350.SGD","LU0943347566.SGD","LU2361044865.SGD","SG9999001176.USD","PJP","XLV","LU0256863902.USD","LU2324357040.USD","LU0006306889.USD","LU0689472784.USD","LU1691799644.USD","LU1720051108.HKD","LU1868836757.USD","IE00BK4W5M84.HKD","LU2168564222.USD","LU0868494617.USD","SG9999015952.SGD","ELIL","IE00BJLML261.HKD","LU2168563687.JPY","LU2237443382.USD","IHE","LU2896262040.SGD","LU1979441026.SGD","LU0353189763.USD","LU1291159041.SGD","LU2111349929.HKD","IE00BBT3K403.USD","LU2237438978.USD","ELIS","LU1551013342.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1093756325.SGD","LU0109394709.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2168564149.EUR","LU2089284900.SGD","LU1127390331.HKD","HRTS","LU0964807845.USD","LU2237443895.HKD","LU2746668974.SGD","LU0225284248.USD","LU2063271972.USD","IE00B2B36J28.USD","IE0004445015.USD","LU0316494557.USD","SG9999018865.SGD","IE000M9KFDE8.USD","LU2089984988.USD","LU2552382058.USD","LU0321505868.SGD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2237443465.HKD","LLYX","LU0133085943.USD","IE00BFSS8Q28.SGD","LU1983299246.USD","LU1066051498.USD","LU0306807586.USD","LU2461242641.AUD","LU2213496289.HKD","LU0094547139.USD","IE0002141913.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0823434740.USD","LU2471134952.CNY","LU2756315664.SGD","LU2756315318.SGD","LU0266013472.USD","BK4581","LU0174119429.USD","LU1917777945.USD","LU2028103732.USD","LU2264538146.SGD","FHLC","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2237443622.USD","LU0345770993.USD","LU2361045086.USD","JDOC","LU0061475181.USD","BK4516","LU0096364046.USD","LU2491050071.SGD","LU2552382132.HKD","LU0097036916.USD","LU0114720955.EUR","LU0122379950.USD","IE00BJJMRY28.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":8,"totalSize":309,"code":"91000000","status":"200"}]}}